AI's Potential in Drug Discovery and Clinical Development

Today’s guest is Ramesh Durvasula, Senior Vice President of R&D IT at Eli Lilly. Ramesh joins Emerj Senior Editor Matthew DeMello on the program today to survey the biggest challenges in biotech research and how emerging capabilities, particularly in generative AI, are paving the way for a new future for the industry. If you’ve enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!